Twist Bioscience Investors Seek $17M Stock Fraud Deal OK
By Bonnie Eslinger · May 1, 2026, 8:55 PM EDT
Twist Bioscience Corp. and two executives asked a California federal court to give preliminary approval to a $17 million deal they inked with investors to resolve class allegations the company misrepresented...
To view the full article, register now.